Similarly, a comparative transcriptomic analysis of grade 2 ependymomas (intermediate risk) and grade 3 ependymomas (high risk) showed that in the latter, there is a decrease in the regulation of CDH-1 (E-cadherin) and the activation of this machinery of destruction. The gene discussed is CDH1; the disease is ependymoma.